FMR LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 1 filers reported holding ANTARES PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$1,200,000
-59.9%
292,966
-65.1%
0.00%
Q4 2021$2,995,000
+1.8%
838,880
+3.8%
0.00%
Q3 2021$2,941,000
-76.2%
807,927
-71.5%
0.00%
-100.0%
Q2 2021$12,342,000
-21.8%
2,830,530
-26.2%
0.00%0.0%
Q1 2021$15,773,000
-15.6%
3,837,741
-18.1%
0.00%
-50.0%
Q4 2020$18,689,000
+54.5%
4,683,999
+4.6%
0.00%
+100.0%
Q3 2020$12,093,000
-4.9%
4,478,768
-3.1%
0.00%0.0%
Q2 2020$12,710,000
+70.8%
4,621,827
+46.6%
0.00%0.0%
Q1 2020$7,441,000
-51.0%
3,152,637
-2.5%
0.00%
-50.0%
Q4 2019$15,196,000
+40.3%
3,233,127
-0.1%
0.00%
+100.0%
Q3 2019$10,831,000
-5.4%
3,237,927
-7.0%
0.00%0.0%
Q2 2019$11,449,000
+10.1%
3,479,927
+1.4%
0.00%0.0%
Q1 2019$10,400,000
+8.4%
3,432,654
-2.7%
0.00%0.0%
Q4 2018$9,596,000
-20.2%
3,527,864
-1.4%
0.00%0.0%
Q3 2018$12,019,000
+28.0%
3,577,155
-1.7%
0.00%0.0%
Q2 2018$9,393,000
+62.8%
3,640,800
+38.8%
0.00%0.0%
Q1 2018$5,769,000
+12.3%
2,622,500
+1.6%
0.00%0.0%
Q4 2017$5,136,000
-45.6%
2,580,900
-11.4%
0.00%0.0%
Q3 2017$9,440,000
+413.9%
2,913,687
+610.7%
0.00%
Q4 2013$1,837,000
-7.7%
410,000
-16.4%
0.00%
Q3 2013$1,991,000
-32.3%
490,500
-30.6%
0.00%
Q2 2013$2,940,000706,7000.00%
Other shareholders
ANTARES PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 500,000$2,180,0004.34%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,535,727$11,056,0003.87%
Sargent Investment Group, LLC 3,596,250$15,680,0003.72%
Rubric Capital Management LP 9,500,000$41,420,0002.61%
PERKINS CAPITAL MANAGEMENT INC 541,783$2,362,0001.34%
ORACLE INVESTMENT MANAGEMENT INC 1,900,000$8,284,0001.14%
Venator Capital Management Ltd. 709,700$3,094,0001.05%
LEVEL FOUR FINANCIAL, LLC 120,000$523,0000.22%
OBERWEIS ASSET MANAGEMENT INC/ 200,600$875,0000.19%
Brown Advisory Securities, LLC 275,000$1,199,0000.19%
View complete list of ANTARES PHARMA INC shareholders